Samit Hirawat, EVP, Chief Medical Officer, and Head of Drug Development at Bristol-Myers Squibb (BMY), completed a purchase of 1,830 shares of common stock on November 1, 2024. The transaction was carried out on the open market at a price of $54.675 per share, resulting in a total investment of $100,055.25. Following this transaction, Hirawat's direct holdings in the company increased to 62,109 shares of common stock.

Samit Hirawat, EVP, Chief Medical Officer, and Head of Drug Development at Bristol-Myers Squibb (BMY), completed a purchase of 1,830 shares of common stock on November 1, 2024. The transaction was carried out on the open market at a price of $54.675 per share, resulting in a total investment of $100,055.25. Following this transaction, Hirawat's direct holdings in the company increased to 62,109 shares of common stock.